Dimerix Ltd has released a press release.
Rights Issue Prospectus
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Dimerix
- Reinstatement to Official Quotation
- Entitlement offer and Convertible Note to raise $12 million
- Voluntary Suspension
- Half-Year Financial Report & Appendix 4D - 31 December 2022
- DXB to Receive $2.8m in Prepayment of R&D Tax Incentive
Later from Dimerix
- Dimerix Announces Update on Successful Capital Raise
- Prospectus
- Dimerix confirms Phase 3 study design appropriate for China
- Approval received for Paediatric Investigation Plan from EMA
- DMX-200 FSGS PH3 Kidney Trial Part 1 Outcome set for Q1 CY24
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix